Meiogenix

Meiogenix develops novel plant breeding technologies that accelerate genetic gain and advanced variety development through targeted recombination, enabling breeders to unlock natural genetic diversity that is inaccessible through conventional methods. The company's proprietary recombination platform addresses the limitation that approximately one-quarter of beneficial genes are inaccessible due to suppressed recombination in cold regions of the genome such as pericentromeric regions. Meiogenix has achieved a 10x increase in targeted recombination in corn, enabling faster trait introgression, linkage drag separation, complex trait combination, and access to deleterious alleles in cold zones. The company serves both specialty crops (tomato, fruits, vegetables) and major field crops (corn, rice, wheat, soybean) through large-scale technology licensing partnerships with license fees, milestones, and royalties. Founded in 2010 and headquartered in Paris, France with US operations in Durham, North Carolina, the company has raised approximately $13 million at the Series A stage.